ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Anxiety"

  • Abstract Number: 314 • 2017 ACR/ARHP Annual Meeting

    Effects of Exercise on Anxiety in Adults with Arthritis: A Systematic Review with Meta-Analysis

    George Kelley1, Kristi Kelley1 and Leigh F. Callahan2, 1Biostatistics, West Virginia University, Morgantown, WV, 2Thurston Arthritis Research Center, University of North Carolina at Chapel Hill, Chapel Hill, NC

    Background/Purpose: Previous randomized controlled trials have led to conflicting findings regarding the effects of exercise on anxiety in adults with arthritis and other rheumatic diseases…
  • Abstract Number: 607 • 2017 ACR/ARHP Annual Meeting

    Secukinumab Treatment of Psoriatic Arthritis and Moderate to Severe Psoriasis Relieves Anxiety/Depression up to 52 Weeks: An Overview from Secukinumab Phase 3 Clinical Trials

    Philip J Mease1, Mark Lebwohl2, Isabelle Gilloteau3, Todd Fox3, Jaime Oliver3, Steffen Jugl3 and Alice B Gottlieb4, 1University of Washington School of Medicine and Swedish Medical Center, Seattle, WA, 2Icahn School of Medicine at Mount Sinai, New York, NY, 3Novartis Pharma AG, Basel, Switzerland, 4Department of Dermatology, New York Medical College, Vallhalla, NY

    Background/Purpose: Secukinumab (SEC), a fully human monoclonal antibody selectively neutralizing interleukin-17A, exhibits significant efficacy, with a favorable safety profile, in the treatment of psoriatic arthritis…
  • Abstract Number: 847 • 2017 ACR/ARHP Annual Meeting

    The Mediational Role of Helplessness in Psychological Outcomes in Systemic Lupus Erythematosus

    Desiree R Azizoddin1, Sarah D. Mills2, Perry M. Nicassio3, Geraldine Zamora Racaza4 and Michael Weisman5, 11611 W Harrison, 1611 W Harrison, Chicago, IL, 2SDSU/UC San Diego Joint Doctoral Program in Clinical Psychology, San Diego, CA, 3Cousins Center for PNI, UCLA, LA, CA, 4Division of Rheumatology, Cedars-Sinai Medical Center, Los Angeles, CA, 5Cedars-Sinai Medical Center Division of Rheumatology, Los Angeles, CA

    Background/Purpose: Systemic lupus erythematosus (SLE) is a chronic, autoimmune disease affecting multiple organs, leading to a significant impact on health-related quality of life. Theoretical models…
  • Abstract Number: 1514 • 2016 ACR/ARHP Annual Meeting

    Symptoms of Depression and Anxiety Predict Worse Disease Activity and Functional Disability in a Cohort of Established Rheumatoid Arthritis Patients

    Christine Iannaccone1, Taysir G. Mahmoud2, Jing Cui3, Michael Weinblatt1 and NA Shadick4, 1Rheumatology, Immunology and Allergy, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, 2Division of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, 3Rheumatology, Immunology, and Allergy, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, 4Rheumatology Immunology & Allergy, Brigham & Women's Hosp, Boston, MA

    Background/Purpose: Depression and anxiety disorders are common in RA patients, with the most recent prevalence estimates indicating that 16.8% of RA patients have a diagnosis…
  • Abstract Number: 1525 • 2016 ACR/ARHP Annual Meeting

    Pain, Physical Function, and Worry (But Not Depression and Poor Sleep) Lead to Greater Fatigue in RA

    Susan J. Bartlett1, Michelle Jones2 and Clifton Bingham III3, 1Department of Medicine, Division of ClinEpi, Rheumatology, Respirology, McGill University, Montreal, QC, Canada, 2Johns Hopkins University School of Medicine, Baltimore, MD, 3Division of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, MD

    Background/Purpose:  Some view fatigue as resulting from disease activity, while others see it as a natural consequence of the pain, disability, and the emotional burden…
  • Abstract Number: 1539 • 2016 ACR/ARHP Annual Meeting

    Physician-Reported and Patient-Reported Anxiety and Depression in Rheumatoid Arthritis

    Nan Li1, Emma Sullivan2, Stuart Blackburn2, Danuta Kielar1 and Steve Peterson1, 1Janssen Research & Development, LLC, Spring House, PA, 2Adelphi Real World, Manchester, United Kingdom

    Background/Purpose:  As many as 40% of people with rheumatoid arthritis (RA) experience significant symptoms of mood disorders. In addition to the pain, fatigue, and disability…
  • Abstract Number: 1701 • 2016 ACR/ARHP Annual Meeting

    The Presence of Depression Might be an Important Determinant of Achieving Minimal Disease Activity State in Psoriatic Arthritis

    Agnes Szentpetery1, Natsumi Ikumi1, Brian Kirby2 and Oliver FitzGerald3, 1St. Vincent's University Hospital, Department of Rheumatology, Dublin, Ireland, 2St. Vincent's University Hospital, Department of Dermatology, Dublin, Ireland, 3St. Vincent's University Hospital, Department of Rheumatology. UCD Conway Institute of Biomolecular and Biomedical Research, University College Dublin, Dublin, Ireland

    Background/Purpose:   Depression and anxiety are well known comorbidities in psoriasis (PsO) and psoriatic arthritis (PsA) with higher prevalence in PsA. Patients with PsA have…
  • Abstract Number: 2040 • 2016 ACR/ARHP Annual Meeting

    Responsiveness of Patient Reported Outcomes Measurement Information System Measures in RA Patients Starting or Switching a DMARD

    Alyssa Wohlfahrt1, Clifton Bingham III2, Zhi Zhang1, Marcy Bolster3, Larry W. Moreland4, Tuhina Neogi5, Kristine Phillips6 and Yvonne C. Lee7, 1Rheumatology, Immunology and Allergy, Brigham and Women's Hospital, Boston, MA, 2Johns Hopkins University, Baltimore, MD, 3Rheumatology, Allergy and Immunology, Massachusetts General Hospital, Boston, MA, 4Rheumatology & Clinical Immunology, University of Pittsburgh, Pittsburgh, PA, 5Clinical Epidemiology, Boston University School of Medicine, Boston, MA, 6Rheumatology, University of Michigan, Ann Arbor, MI, 7Rheumatology Immunology & Allergy, Brigham and Women's Hospital and Harvard Medical School, Boston, MA

    Background/Purpose: The Patient Reported Outcome Measurement Information System (PROMIS) is an NIH-developed metric for assessing multidimensional aspects of health across different conditions. Prior RA studies…
  • Abstract Number: 3085 • 2016 ACR/ARHP Annual Meeting

    Do Depression and Anxiety Reduce the Chance of Remission in Rheumatoid Arthritis and Psoriatic Arthritis?

    Brigitte Michelsen1,2, Karen M Fagerli1, Elisabeth Lie1, Hilde Berner Hammer3, Glenn Haugeberg4,5, Eirik K Kristianslund1 and Tore K. Kvien1, 1Dept. of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway, 2Dept. of Rheumatology, Hospital of Southern Norway Trust, Kristiansand, Norway, 3Rheumatology, Diakonhjemmet Hospital, Oslo, Norway, 4Dept. of Rheumatology, Martina Hansens Hospital, Bærum, Norway, 5Dept. of Rheumatology, The Norwegian University of Science and Technology, Trondheim, Norway

    Background/Purpose: Depression and anxiety are reported to predict poorer treatment outcomes in rheumatoid arthritis (RA).1 Whether this can be confirmed in larger, prospective studies as…
  • Abstract Number: 3234 • 2016 ACR/ARHP Annual Meeting

    Prevalence and Metric of Depression and Anxiety in Lupus: A Systematic Review and Meta-Analys

    Ahmed Moustafa1, Mohamed Hassanein2, Lihi Eder3, Joan E. Wither4, William Fung5, Panayiotis Lambiris6 and Zahi Touma4, 1Medicine, Western University, London, ON, Canada, 2Michigan State University, East Lansing, MI, 3Medicine, University of Toronto, Women's College Hospital, Toronto, ON, Canada, 4Rheumatology, University of Toronto, Toronto Western Hospital, Toronto, ON, Canada, 5Medicine, University of Toronto, Toronto, ON, Canada, 6University Health Network, Toronto, ON, Canada

    Background/Purpose:  To systematically review the literature on the: 1) prevalence of depression and anxiety in SLE patients and 2) metrics of depression and anxiety.  …
  • Abstract Number: 2305 • 2015 ACR/ARHP Annual Meeting

    Relationship Between Anxiety, Depression, Sleep, Fibromyalgia and BMI in Patients with Rheumatic Disease

    Shazia Bég1 and Ali Ahmad2, 1Rheumatology, University of Central Florida, Orlando, FL, 2University of Central Florida, Orlando, FL

    Background/Purpose: Patients with rheumatic diseases often have comorbidities that complicate their psychological well-being and affect prognosis. In this study, we looked at 216 patients with…
  • Abstract Number: 2474 • 2015 ACR/ARHP Annual Meeting

    Psychometric Properties of the Social Appearance Anxiety Scale in Patients with Limited and Diffuse Systemic Sclerosis: Analysis from the Scleroderma Patient-Centered Intervention Network Cohort

    Sarah D. Mills1, Shadi Gholizadeh1, Rina S. Fox1, Lisa R. Jewett2,3, Marie-Eve Carrier3, Linda Kwakkenbos2,3, Karen Gottesman4, Scott C. Roesch1,5, Brett D. Thombs2,3, Vanessa L. Malcarne1,5 and SPIN Investigators6, 1SDSU/UC San Diego Joint Doctoral Program in Clinical Psychology, San Diego, CA, 2McGill University, Montreal, QC, Canada, 3Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, QC, Canada, 4Scleroderma Foundation, Los Angeles, CA, 5Psychology, San Diego State University, San Diego, CA, 6Scleroderma Patient-centered Intervention Network, Montreal, QC, Canada

    Background/Purpose: Despite the common appearance changes in patients with systemic sclerosis (SSc), and the potential adverse psychosocial impact of such changes, research in this area…
  • Abstract Number: 2628 • 2015 ACR/ARHP Annual Meeting

    Identifying Anxiety and Depression Among Rheumatoid Arthritis Patients Using the Multidimensional Health Assessment Questionnaire

    Naoto Yokogawa1, Tetsuji Kaneko2, Yoshiki Nagai1, Takahiro Nunokawa3, Toshioki Sawaki3, Katsuaki Shiroto3, Kota Shimada3 and Shoji Sugii3, 1Department of Rheumatic Diseases, Tokyo Metropolitan Tama Medical Center, Tokyo, Japan, 2Division of Clinical Research Support Center, Tokyo Metropolitan Children’s Medical Center, Fuchu, Japan, 3Department of Rheumatic Diseases, Tokyo Metropolitan Tama Medical Center, Fuchu, Japan

    Background/Purpose: The Multidimensional Health Assessment Questionnaire (MDHAQ) was designed to assess quality of life impairment including psychological distress in rheumatoid arthritis (RA) patients. In addition…
  • Abstract Number: 2684 • 2015 ACR/ARHP Annual Meeting

    Association Between Anxiety and Depression and Rheumatoid Arthritis Outcome: Results from an Inception Early Rheumatoid Arthritis Cohort

    Sizheng Zhao1,2, Samantha Hider3, Christopher Sparks2, Faith Matcham4, James Galloway5, Cristina Estrach1 and Nicola Goodson1,2, 1Department of Rheumatology, Aintree University Hospital, Liverpool, United Kingdom, 2Musculoskeletal Biology I, Institute of Ageing and Chronic Disease, University of Liverpool, Liverpool, United Kingdom, 3Research Institute for Primary Care and Health Sciences, Keele University, Keele, United Kingdom, 4Psychological Medicine Clinical Academic Group, King's College London, London, United Kingdom, 5Academic Department of Rheumatology, King´s College London, London, United Kingdom

    Background/Purpose: Anxiety and depression (A&D) are important comorbid conditions that affect patients with rheumatoid arthritis (RA). It is not known whether they impact on disease…
  • Abstract Number: 44 • 2015 ACR/ARHP Annual Meeting

    The Prevalence of Depression and Anxiety in a Cross-Section of Rheumatological Conditions

    Faith Matcham1, Nicola J. Gullick2, Matthew Hotopf3, Sam Norton4, Sophia Steer5 and James Galloway6, 1Psychological Medicine Clinical Academic Group, King's College London, London, United Kingdom, 2Rheumatology, Department of Rheumatology, King`s College Hospital NHS Foundation Trust, London, United Kingdom, 3Department of Psychological Medicine, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, United Kingdom, 4Institute of Psychiatry, King's College London, London, United Kingdom, 5Rheumatology Dept, Kings College Hospital, London, United Kingdom, 6Academic Department of Rheumatology, King´s College London, London, United Kingdom

    Background/Purpose: Depression and anxiety have detrimental effects on quality-of-life, treatment response and disease outcomes. Whilst psychological morbidity has been described in individual rheumatic diseases, less…
  • « Previous Page
  • 1
  • …
  • 4
  • 5
  • 6
  • 7
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology